A bitter pill

The Novartis case highlights the need for innovation in the public interest.

Read More
Publication Date: 
24/09/2012
Kaushik Sunder Rajan
Indian Express (New Delhi)
Tags:
Drugs, Drug Industry, Health, Health Care, Supreme Court, Intellectual Property Rights (IPR), Parliament